Verition Fund Management’s Evolent Health EVH Stock Holding History

Verition Fund Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-42,700	Closed	-$386K	–	748
2019 Q4	$386K	Buy	+42,700	New	+$347K	0.01%	765

Other funds holding EVH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Verition Fund Management's EVH Position: Q1 2026 in Review

Verition Fund Management sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 42,700 shares — an estimated $171K sold.

Verition Fund Management first reported a position in EVH in Q4 2016 and held it in 15 quarters. The position peaked at $1.73M in Q2 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

Verition Fund Management reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
Verition Fund Management sold 42,700 Evolent Health shares in Q1 2026, an estimated $171K.
Verition Fund Management first reported a position in Evolent Health in Q4 2016 and held it in 15 quarters.
Verition Fund Management's Evolent Health position peaked at $1.73M in Q2 2025.
191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.